Tools
Tools
Vidya, Raghavan, Athwal, Ruvinder, Huissoon, Aarnoud P, Baretto, Richard L and Thirumala Krishna, Mamidipudi Diagnostic application of patent blue V in sentinel lymph node biopsy for breast cancer - Is it time for a change? Indian journal of cancer, 56 (3). pp. 269-270. ISSN 1998-4774. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
|
Text (PDF file format)
IndianJournalofCancer563269-3439618_093316.pdf - Published Version Available under License Creative Commons Attribution Non-commercial Share Alike 4.0. Download (264kB) | Preview |
Abstract
Sentinel lymph node biopsy (SLNB) was introduced in the 1990s, as a minimally invasive procedure for staging the axilla with less morbidity to the traditional axillary lymph node dissection and is now standard management of the axilla in the early breast cancer. SLNB using the combined technique of blue dye and radioisotope is currently the recommended method for lymphatic mapping, and studies have shown high identification rates (IR) (>95%) and low false-negative rates (FNR) 5-10%. However, there are several reports raising awareness regarding patent blue V dye-induced peri-operative anaphylaxis. The main aim of this article is to highlight the emergence of patent blue dye as a new allergen and present evidence regarding the utility of alternative safer methods of evaluation of early breast cancer without compromising IR.
| Item Type: | Article |
|---|---|
| Additional Information: | This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs |
| Subjects: | WP Gynaecology. Women’s health |
| Divisions: | Clinical Support > Pathology |
| Related URLs: | |
| Depositing User: | Mrs Yolande Brookes |
| Date Deposited: | 09 Aug 2019 13:45 |
| Last Modified: | 09 Aug 2019 13:45 |
| URI: | http://www.repository.uhblibrary.co.uk/id/eprint/2296 |
Actions (login required)
 |
View Item |
